University of California, San Diego

A Ligand Field Molecular Mechanics Study of CO2-Induced Breathing in the Metal–Organic Framework DUT-8(Ni) (2019) Melix P, Paesani F, Heine T Journal article Matched-paired analysis of patients treated for invasive mucormycosis: Standard treatment versus posaconazole new formulations (MoveOn) (2019) Salmanton-Garcia J, Seidel D, Köhler P, Mellinghoff SC, Herbrecht R, Klimko N, Racil Z, et al. Journal article Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study (2019) Feagan BG, Sandborn WJ, D'Haens GR, Panes J, Kaser A, Ferrante M, Louis E, et al. Conference contribution Leptin and Associated Mediators of Immunometabolic Signaling: Novel Molecular Outcome Measures for Neurostimulation to Treat Chronic Pain (2019) Kinfe TM, Buchfelder M, Chaudhry SR, Chakravarthy KV, Deer TR, Russo M, Georgius P, et al. Journal article, Review article Chasing copper hydrides (2019) Peltier J, Romero E, Munz D, Jazzar R, Bertrand G Conference contribution Exploring the complex etiology of oncogenic fusions in childhood cancer (2019) Anderson ND, De Borja R, Young MD, Fuligni F, Rosic A, Roberts ND, Pillay N, et al. Conference contribution Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis (2019) Starkel P, Schnabl B, Leclercq S, Komuta M, Bataller R, Argemi J, Palma E, et al. Journal article Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease (2019) Sommer A, Marxreiter F, Krach F, Fadler T, Grosch J, Maroni M, Gräf D, et al. Journal article, Erratum DUAL NEUTRALISATION OF IL-17A AND IL-17F WITH BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSA: OVERALL AND TNF-INHIBITOR-NAIVE POPULATION RESULTS FROM A 48-WEEK PHASE 2B RANDOMISED STUDY (2019) Ritchlin CT, Kavanaugh A, Merola JF, Schett G, Scher JU, Warren RB, Assudani D, et al. Conference contribution Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysis (2019) Kavanaugh A, Gladman DD, Edwards CJ, Schett G, Guerette B, Delev N, Teng L, et al. Journal article